![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 31, 2014 8:09:02 PM
Conversation on twr
$AMBS congrats all. #LymPro V1 interim data (p=0.003) exceeded even my calculations. Take a bow, Dr. Thomas Arendt. Stay tuned for LymPro V2
Expand
Reply
Retweeted
Favorited
jbplens ?@jbplens 50m
@fibonacci1170 source of this information?
Expand
Reply
Retweet
Favorite
Retweeted by nj46nick
fibonacci ?@fibonacci1170 32m
@jbplens $AMBS presented univariate results w/o any stat modeling. Bridge study will compare Alz vs cognitively intact controls. Can top 95% Less
Sentiment: Strong Buy
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM